Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study
- PMID: 30298907
- DOI: 10.1111/dmcn.14055
Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study
Abstract
Aim: We aimed to study tuberous sclerosis-associated neuropsychiatric disorders (TAND) in children and adolescents with tuberous sclerosis complex (TSC).
Method: Retrospective and prospective cohort study conducted at a Paediatric Neurology Unit of an Italian Tertiary Care Hospital. Clinical and neuroimaging data were reviewed. Scores for neurological and epilepsy outcomes (Extended Glasgow Outcome Scale, Paediatric Version and Early Childhood Epilepsy Severity Scale modified), semi-structured interviews (authorized Italian version of the TAND checklist and Vineland Adaptive Behavior Scales) and questionnaires (Child Behavior Checklist [CBCL]) were applied at last follow-up.
Results: Thirty-two patients with TSC (age range 1-19y) were enrolled. Eighty-eight per cent had at least one TAND and 47% had intellectual disability. The TAND checklist showed internalizing problems in 25.8% of cases (vs 41.9% by CBCL), and externalizing problems in 41.9% (vs 9.7% by CBCL). TAND prevailed in patients with de novo mutation of TSC2, high tuber load, and severe neurological and epilepsy outcomes.
Interpretation: In our cohort, 78% of patients had more than four TAND behavioural problems; nevertheless, they did not show a constant and specific neuropsychiatric profile. Clinical, neurophysiological, and neuroradiological features were associated with several TAND. The TAND checklist appeared more effective than the CBCL, particularly in detecting externalizing problems.
What this paper adds: The Tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist is an effective tool for TAND screening. The TAND checklist helps define psychopathological and neuropsychiatric aspects in paediatric patients with Tuberous sclerosis complex (TSC). TAND were found in 88% of patients with TSC, whilst 78% had more than four TAND. TAND distribution depends on different clinical and neuroradiological features.
© 2018 Mac Keith Press.
Comment in
-
Best use of the tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) checklist.Dev Med Child Neurol. 2019 Feb;61(2):112-113. doi: 10.1111/dmcn.14089. Epub 2018 Oct 31. Dev Med Child Neurol. 2019. PMID: 30378680 No abstract available.
Similar articles
-
Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study.Neuropediatrics. 2019 Oct;50(5):294-299. doi: 10.1055/s-0039-1693042. Epub 2019 Jul 2. Neuropediatrics. 2019. PMID: 31266065
-
The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.Orphanet J Rare Dis. 2020 Sep 7;15(1):237. doi: 10.1186/s13023-020-01488-4. Orphanet J Rare Dis. 2020. PMID: 32894194 Free PMC article.
-
Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.Pediatr Neurol. 2015 Jan;52(1):25-35. doi: 10.1016/j.pediatrneurol.2014.10.004. Epub 2014 Oct 16. Pediatr Neurol. 2015. PMID: 25532776 Free PMC article.
-
[Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].Z Kinder Jugendpsychiatr Psychother. 2019 Mar;47(2):139-153. doi: 10.1024/1422-4917/a000604. Epub 2018 Aug 6. Z Kinder Jugendpsychiatr Psychother. 2019. PMID: 30080117 Review. German.
-
The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.J Neurodev Disord. 2022 Feb 13;14(1):13. doi: 10.1186/s11689-022-09423-3. J Neurodev Disord. 2022. PMID: 35151277 Free PMC article.
Cited by
-
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex.Front Neurol. 2020 Aug 11;11:639. doi: 10.3389/fneur.2020.00639. eCollection 2020. Front Neurol. 2020. PMID: 32849171 Free PMC article.
-
Diagnosis and treatment considerations of atypical oral pain in tuberous sclerosis.J Family Med Prim Care. 2020 Apr 30;9(4):2121-2124. doi: 10.4103/jfmpc.jfmpc_1213_19. eCollection 2020 Apr. J Family Med Prim Care. 2020. PMID: 32670978 Free PMC article.
-
Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population.J Clin Med. 2022 Nov 3;11(21):6536. doi: 10.3390/jcm11216536. J Clin Med. 2022. PMID: 36362764 Free PMC article.
-
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).PLoS One. 2025 Jun 12;20(6):e0324648. doi: 10.1371/journal.pone.0324648. eCollection 2025. PLoS One. 2025. PMID: 40504787 Free PMC article.
-
Review of the spectrum of tuberous sclerosis complex: The Saudi Arabian Experience.Neurosciences (Riyadh). 2024 May;29(2):113-121. doi: 10.17712/nsj.2024.2.20230061. Neurosciences (Riyadh). 2024. PMID: 38740395 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical